Navigation Links
Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2008 and Updates 2008 Full Year Guidance
Date:11/10/2008

8.4% and the marginal tax rate for amortization and write-off of deferred financing costs was 16.4%.

Liquidity, Balance Sheet and Cash Flows

As of September 30, 2008, our cash and cash equivalents totaled $13.2 million and our total debt outstanding was $1,034.2 million. There were no borrowings outstanding under the revolving portion of our senior secured credit facility. We generated $90.0 million of cash from operating activities in the quarter ended September 30, 2008, compared with $42.0 million of cash from operating activities in the prior year quarter, an increase of $48.0 million. The increase in cash flows from operating activities is primarily due to the increase in net income for the quarter ended September 30, 2008 as compared to the prior year quarter.

2008 Financial Guidance Update

Based on the year to date results and current outlook for the remainder of 2008, the Company is updating its full year 2008 financial guidance. For 2008, the Company continues to anticipate revenue to be in the range of $935 to $945 million.

Total gross margin as a percentage of revenue is now expected to be in the range of 79.0% to 80.0%, a decrease of 1.0% from the guidance of 80.0% to 81.0% given in August 2008. This primarily reflects changes in product mix and a general increase in costs.

Total SG&A expenses are now expected to be in the range of $192 to 201 million, a decrease of $16 million from the guidance of $208 to $217 million given in August 2008. This reflects an overall reduction in anticipated expenses, primarily related to A&P spend and legal fees.

Total R&D expenses are now expected to be between $50 and $53 million, a decrease of $14 million from the guidance given in August 2008. The revised guidance excludes $10.0 million of milestone payments to third parties previously anticipated to be incurred during the second half of 2008. The further reductions reflect our most current estimates with regards to the
'/>"/>

SOURCE Warner Chilcott Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2008 Financial Results
2. House Passes Historic Bill to Protect Kids From Tobacco; Senators Webb & Warner Should Cosponsor Legislation
3. Fitness and Figure Professionals Kirsten Nicewarner and Michelle Adams to Represent GNC at Vails Teva Mountain Games
4. The Oregon Clinic Extends Patient Care Services Across Metro Portland with Time Warner Telecoms Metro Ethernet Service
5. Warner Chilcott Announces Settlement of Securities Litigation
6. LodgeNet Appoints John E. Haire, Former Time Warner Executive, to Board of Directors
7. CooperVision Increases Network Performance While Reducing Costs With Time Warner Telecoms IP VPN
8. Sharing Miracles Television Program to Feature Mountain Climber and Cancer Survivor Sean Swarner
9. Pinstripe Healthcare Group Adds Veteran HR Executive Warner as Client Services Director
10. Warner Chilcott Announces 2008 Financial Guidance
11. Warner Chilcott to Present at the 2008 Wachovia Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3The Army Awards Follow-On Contract for Autonomous Airway Management to Energid Technologies 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 3Simulating medical situations helps students learn retain basic science concepts 51568 1Simulating medical situations helps students learn retain basic science concepts 51568 2July August 2009 Annals of Family Medicine tip sheet 51565 1July August 2009 Annals of Family Medicine tip sheet 51565 2July August 2009 Annals of Family Medicine tip sheet 51565 3July August 2009 Annals of Family Medicine tip sheet 51565 4July August 2009 Annals of Family Medicine tip sheet 51565 5July August 2009 Annals of Family Medicine tip sheet 51565 6July August 2009 Annals of Family Medicine tip sheet 51565 7New drugs faster from natural compounds 3A A UC San Diego breakthrough 13003 1New drugs faster from natural compounds 3A A UC San Diego breakthrough 13003 2New drugs faster from natural compounds 3A A UC San Diego breakthrough 13003 3New drugs faster from natural compounds 3A A UC San Diego breakthrough 13003 4